| Ytd | 15.29% | |
| 1y | 28.02% |
| Open | 257.73 | Prev Close | 258.88 | Low | 258.71 | High | 263.50 | Mkt Cap | 42.78B |
| Vol | 972.34K | Avg Vol | 1.45M | EPS | 8.05 | P/E | 32.28 | Forward P/E | 18.02 |
| Beta | 1.17 | Short Ratio | 3.08 | Inst. Own | 103.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-27 | 50-d Avg | 256.42 | 200-d Avg | 206.62 | 1yr Est | 295.05 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinic
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinic
Mizuho analyst Ann Hynes maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the pri
Barclays analyst Luke Sergott maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises th
RBC Capital analyst Ryan Halsted maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises
Truist Securities analyst Jailendra Singh reiterates IQVIA Holdings (NYSE:IQV) with a Buy and rai
Morgan Stanley analyst Kallum Titchmarsh maintains IQVIA Holdings (NYSE:IQV) with a Equal-Weight
Looking ahead to 2030, our model projects IQV could trade at an average price of $399.85, with a pot